ARCHIVES

John Durant “Going Home” To Birmingham

This article is from The Cancer Letter archive.

Vol. 14 No. 06 | February 5, 1988

Download PDF Visit The Full Archive

Related Articles

Vanderbilt Recruits Sosman To Lead Tumor Immunology.

January 18, 2002

FDA Expands Gleevec Indication For Children with Ph+ ALL

January 25, 2013

Blistering Resignation Letters Declare CPRIT Outside Mainstream of Science

October 12, 2012

Peter Shields Named Deputy Director At Ohio State

September 16, 2011

Advisors Recommend Listing Estrogen As Carcinogen.

January 12, 2001

Phase III Afatinib Trial Met Primary Endpoint In Stage IIIb or IV Cancer with EGFR Mutation

June 29, 2012